1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Evofem Biosciences Inc (EVFM)
  7. News

EVFM

Evofem Biosciences News

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Evofem Biosciences Inc EVFM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.005 0.49% 1.035 10:49:10
Open Price Low Price High Price Close Price Prev Close
1.04 1.01 1.05 1.03
more quote information »

Recent News

Date Time Source Heading
5/19/20228:00IHNWFeaturedEdison Lithium Spin-Out of Cobalt Assets
5/19/20228:00IHNWFeaturedGoldshore Resources Announces Innovative Technology Application for Moss Lake Project Exploration and Closing of Non-Brokered Financing
5/18/202211:48IHNWFeaturedEmerging Markets Report: Details, Details
5/12/202208:02EDGARCurrent Report Filing (8-k)
5/11/202207:50TRMNMorgan Stanley Remains a Sell on Evofem Biosciences (EVFM)
5/10/202217:05EDGARQuarterly Report (10-q)
5/10/202208:46PRNUSEvofem Biosciences to Decrease Cost of Goods 45 Percent..
5/06/202216:12EDGARStatement of Changes in Beneficial Ownership (4)
5/06/202216:12EDGARStatement of Changes in Beneficial Ownership (4)
5/06/202216:11EDGARStatement of Changes in Beneficial Ownership (4)
5/06/202216:11EDGARStatement of Changes in Beneficial Ownership (4)
5/06/202216:10EDGARStatement of Changes in Beneficial Ownership (4)
5/06/202208:46PRNUSEvofem Presents Data Detailing Fewer Urinary Tract..
5/05/202209:04EDGARCurrent Report Filing (8-k)
5/05/202209:00PRNUSEvofem Biosciences Announces 1-for-15 Reverse Stock Split
5/04/202216:01PRNUSEvofem Biosciences Reports First Quarter 2022 Financial..
4/27/202208:46PRNUSEvofem Improves Phexxi® Patient Experiences Through New..
4/26/202208:46PRNUSEvofem to Present New Research in Gynecological Health at..
4/25/202209:00PRNUSEvofem Biosciences to Report First Quarter 2022 Results and..
4/19/202206:52PRNUSJournal of Sexual Medicine Publishes Sexual Satisfaction..
4/13/202205:45TRMNAnalysts Offer Insights on Healthcare Companies:..
4/11/202206:48PRNUSEvofem Announces Karina Fedasz as Company's New Head of..
4/07/202216:57EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/07/202207:18SEEKEvofem Biosciences regains approval for Nasdaq listing..
4/07/202206:53EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/07/202206:52EDGARCurrent Report Filing (8-k)
4/07/202206:50PRNUSNasdaq Accepts Evofem Plan to Regain Listing Compliance
3/31/202213:00PRNUSEvofem Presents Positive Encore Data in Sexually Transmitted..
3/24/202216:04EDGARCurrent Report Filing (8-k)
3/18/202217:12EDGARProxy Statement - Notice of Shareholders Meeting..
3/10/202216:14EDGARSecurities Registration: Employee Benefit Plan (s-8)
3/10/202216:05EDGARAnnual Report (10-k)
3/04/202210:01SEEKEvofem Biosciences declines 5% after bottom line earnings..
3/04/202206:48PRNUSEvofem Completes Enrollment in EVOGUARD Phase 3 Clinical..
3/03/202216:14EDGARCurrent Report Filing (8-k)
3/03/202216:04SEEKEvofem Biosciences GAAP EPS of -$0.33 misses by $0.10,..
3/03/202216:00PRNUSEvofem Biosciences Reports Fourth Quarter and Year-End 2021..
3/02/202217:35SEEKEvofem Biosciences Q4 2021 Earnings Preview
3/01/202216:22EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
3/01/202210:54EDGARCurrent Report Filing (8-k)
2/28/202216:21EDGARCurrent Report Filing (8-k)
2/23/202216:08EDGARStatement of Changes in Beneficial Ownership (4)
2/23/202216:05EDGARStatement of Changes in Beneficial Ownership (4)
2/17/202209:00PRNUSEvofem Biosciences to Report Fourth Quarter and Year-End..
2/16/202216:07EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
2/16/202216:06EDGARAmended Current Report Filing (8-k/a)
2/16/202206:23EDGARCurrent Report Filing (8-k)
2/15/202216:11EDGARCurrent Report Filing (8-k)
2/14/202215:31EDGARAmended Statement of Ownership (sc 13g/a)
2/09/202209:00PRNUSFDA Awards QIDP Designation for Prevention of Chlamydia to..
2/08/202209:00PRNUSEvofem Biosciences to Present at Aegis Virtual Conference on..
1/19/202209:44SEEKEvofem Biosciences jumps 7% on record prelim net sales and..
1/19/202209:02EDGARCurrent Report Filing (8-k)


Your Recent History
NASDAQ
EVFM
Evofem Bio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.